Therapeutic Targeting of the Anaplastic Lymphoma Kinase (ALK) in Neuroblastoma-A Comprehensive Update
Neuroblastoma (NBL) is an embryonic malignancy of the sympathetic nervous system and mostly affects children under the age of five. NBL is highly heterogeneous and ranges from spontaneously regressing to highly aggressive disease. One of the risk factors for poor prognosis are aberrations in the rec...
Saved in:
Main Authors: | Annette K. Brenner (Author), Maria W. Gunnes (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Insight into systematic development of ALK (anaplastic lymphoma kinase) inhibitors towards NSCLC treatment
by: Vivek Yadav, et al.
Published: (2024) -
Analysis of Histologic Features Suspecting Anaplastic Lymphoma Kinase (ALK)-Expressing Pulmonary Adenocarcinoma
by: In Ho Choi, et al.
Published: (2015) -
Pathobiology of ALK-negative anaplastic large cell lymphoma
by: Stefano A. Pileri, et al.
Published: (2011) -
Educational Case: ALK-Negative Anaplastic Large Cell Lymphoma
by: Akira Satou MD, PhD, et al.
Published: (2020) -
Immunohistochemical expression of anaplastic lymphoma kinase in neuroblastoma and its relations with some clinical and histopathological features
by: Thu Dang Anh Phan, et al.
Published: (2024)